The new tumor biomarker miRNA-371a-3p in testicular germ cell tumours: First insights into the molecular function in vitro

被引：0
|
作者：
Weiten, R. [1 ]
Engler, T. [1 ]
Schorle, H. [2 ]
Ellinger, J. [1 ]
Alajati, A. [1 ]
Ritter, M. [1 ]
Nettersheim, D. [3 ,4 ]
Syring-Schmandke, I. [1 ]
机构：
[1] Univ Hosp Bonn, Dept Urol, Bonn, Germany
[2] Univ Hosp Bonn, Inst Pathol, Bonn, Germany
[3] Univ Hosp Dusseldorf, Urol Res Lab, Translat UroOncol, Med Fac, Dusseldorf, Germany
[4] Univ Hosp Dusseldorf, Urol Res Lab, Translat UroOncol, Dusseldorf, Germany
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0660
引用
收藏
页码：S908 / S908
页数：1
相关论文
共 50 条
  • [1] Potential next generation markers of testicular germ cell tumors: miRNA-371a-3p
    Zujuan, Shan
    Xin, Deng
    Yang, Hongping
    Guifu, Zhang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025, 57 (03) : 691 - 700
  • [2] The new tumor biomarker miRNA-371-3p is involved in mediating cisplatin resistance in testicular germ cell tumor cell lines
    Engler, T.
    Weiten, R.
    Schorle, H.
    Ellinger, J.
    Alajati, A.
    Ritter, M.
    Nettersheim, D.
    Syring-Schmandke, I.
    EUROPEAN UROLOGY, 2021, 79 : S907 - S907
  • [3] Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
    Christiansen, Ailsa J.
    Lobo, Joao
    Fankhauser, Christian D.
    Rothermundt, Christian
    Cathomas, Richard
    Batavia, Aashil A.
    Grogg, Josias B.
    Templeton, Arnoud J.
    Hirschi-Blickenstorfer, Anita
    Lorch, Anja
    Gillessen, Silke
    Moch, Holger
    Beyer, Joerg
    Hermanns, Thomas
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell Lines
    Weiten, Richard
    Engler, Theadora
    Schorle, Hubert
    Ellinger, Joerg
    Saponaro, Miriam
    Alajati, Abdullah
    Nettersheim, Daniel
    Syring-Schmandke, Isabella
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (24)
  • [5] EVALUATION OF MIRNA-371A-3P (MIR371A) ASSAY IN PATIENTS UNDERGOING INGUINAL ORCHIDECTOMY OR ENUCLEATION FOR SUSPECTED TESTICULAR TUMOR
    Seelemeyer, Felix
    Pfister, David
    Pappesch, Roberto
    Markelbach-Bruse, Sabine
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2024, 211 (05): : E6 - E6
  • [6] MicroRNA-371a-3p-The Novel Serum Biomarker in Testicular Germ Cell Tumors
    Nestler, Tim
    Schoch, Justine
    Belge, Gazanfer
    Dieckmann, Klaus-Peter
    CANCERS, 2023, 15 (15)
  • [7] Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours
    Bagrodia, Aditya
    Savelyeva, Anna
    Lafin, John T.
    Speir, Ryan W.
    Chesnut, Gregory T.
    Frazier, Anne Lindsay
    Woldu, Solomon L.
    Margulis, Vitaly
    Murray, Matthew J.
    Amatruda, James F.
    Lotan, Yair
    BJU INTERNATIONAL, 2021, 128 (01) : 57 - 64
  • [8] Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
    Dieckmann, Klaus-Peter
    Radtke, Arlo
    Spiekermann, Meike
    Balks, Thomas
    Matthies, Cord
    Becker, Pascal
    Ruf, Christian
    Oing, Christoph
    Oechsle, Karin
    Bokemeyer, Carsten
    Hammel, Johannes
    Melchior, Sebastian
    Wosniok, Werner
    Belge, Gazanfer
    EUROPEAN UROLOGY, 2017, 71 (02) : 213 - 220
  • [9] MicroRNA miR-371a-3p in serum: A sensitive and specific new biomarker for (testicular) germ cell tumors
    Zengerling F.
    Der Onkologe, 2017, 23 (5): : 389 - 390
  • [10] Utility of miRNA miR-371a-3p for the early detection of metastases in testicular germ cell tumors
    Pappesch, Roberto
    Seelemeyer, Felix
    Merkelbach-Bruse, Sabine
    Heidenreich, Axel
    Siebolts, Udo
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 139 - 139
12345